Use of antiretroviral drugs to prevent HIV-1 transmission through breast-feeding: from animal studies to randomized clinical trials.
about
Pharmacokinetics of tenofovir in breast milk of lactating rhesus macaques.The cost-effectiveness of different feeding patterns combined with prompt treatments for preventing mother-to-child HIV transmission in South Africa: estimates from simulation modeling.Evaluating nurses' implementation of an infant-feeding counseling protocol for HIV-infected mothers: The Ban Study in Lilongwe, MalawiDifferences between international recommendations on breastfeeding in the presence of HIV and the attitudes and counselling messages of health workers in Lilongwe, MalawiGenetic analysis of simian immunodeficiency virus expressed in milk and selectively transmitted through breastfeeding.Using formative research to develop a context-specific approach to informed consent for clinical trials.Challenges in the design of HIV prevention trials in the United States.Current issues in the prevention of mother-to-child transmission of HIV-1 infection.(C2) Saliva, breast milk, and mucosal fluids in HIV transmission.Field efficacy of zidovudine, lamivudine and single-dose nevirapine to prevent peripartum HIV transmission.Acceptability of exclusive breast-feeding with early cessation to prevent HIV transmission through breast milk, ANRS 1201/1202 Ditrame Plus, Abidjan, Côte d'Ivoire.Children and HIV/AIDS: from research to policy and action in resource-limited settingsInvolving communities in the design of clinical trial protocols: the BAN Study in Lilongwe, MalawiDifficult choices: infant feeding experiences of HIV-positive mothers in northern Tanzania.Tackling HIV and AIDS: contributions by non-human primate models.Biochemical analysis of human milk treated with sodium dodecyl sulfate, an alkyl sulfate microbicide that inactivates human immunodeficiency virus type 1.
P2860
Q33770127-0384C476-E0D0-497C-8F06-C67AF3F715EBQ33940190-ABBB813E-A9BD-4D93-ACF7-FD06783FD6C3Q33990216-55D4E5C2-8847-4CD2-BBF4-42B0A292EF57Q34538622-98E4F3BD-D09A-4047-A0C1-A017837F1C2EQ34545829-2F981A4D-4BF9-44B9-8B2D-F229082ACB24Q35116953-4A71DE3E-56E7-4E5E-B22E-03A572EBBE8CQ35819672-86E6A01B-0DE0-4962-96F3-1799486362A7Q36281309-7161E0AB-3CFC-4229-B09E-A82AEFFCB295Q36467686-ED945425-3E3B-474D-B071-370E3AC6F44FQ36776545-2EB68999-41D8-4D8A-B86D-4B305A0DFD19Q36777584-5E1B87A2-3B3C-499C-8103-07A542A65D77Q37143745-12C8E13C-6CE1-4293-A6FD-62BFB0CD3362Q37205944-BC9A4B70-FF44-40B5-AF05-01AC0A3C2009Q39171986-7C4033F3-251F-4D08-9B96-29941AD814B6Q40191155-2F428638-98F9-49A4-A37C-37DDD65F66A5Q45419969-B59EB6AE-3B02-4DAC-81C1-CC61E2134F8C
P2860
Use of antiretroviral drugs to prevent HIV-1 transmission through breast-feeding: from animal studies to randomized clinical trials.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Use of antiretroviral drugs to ...... to randomized clinical trials.
@ast
Use of antiretroviral drugs to ...... to randomized clinical trials.
@en
type
label
Use of antiretroviral drugs to ...... to randomized clinical trials.
@ast
Use of antiretroviral drugs to ...... to randomized clinical trials.
@en
prefLabel
Use of antiretroviral drugs to ...... to randomized clinical trials.
@ast
Use of antiretroviral drugs to ...... to randomized clinical trials.
@en
P2093
P50
P921
P1476
Use of antiretroviral drugs to ...... to randomized clinical trials.
@en
P2093
Andrea Ruff
Charles Van Der Horst
Ghent IAS Working Group on HIV in Women and Children
Isabelle De Vincenzi
Koen Van Rompay
Mary-Glenn Fowler
Philippe Gaillard
Tim Thomas
P304
P356
10.1097/00126334-200402010-00013
P407
P577
2004-02-01T00:00:00Z